Signals, Powered By EquityPandit
Biocon has reported approx 2% growth in its net profit at Rs.130 crore, for the quarter ended March 31,2018. The company in the same quarter last fiscal, had posted a profit of Rs.127 crore.
Its total revenue for the quarter under review was up 27% to Rs.1,237 crore, while for the corresponding quarter last year it was at Rs.974 crore. Its net profit for the whole year was down 39% to Rs.372 crore for FY18, as against Rs.612 crore for FY17.
Furthermore, as per the company’s filing to BSE, its board has recommended a final dividend of Re.1 per equity share of face value of Rs.5 each.
